Completed Cancer Heart, Stroke & Blood
CALR mutations and human myeloproliferative neoplasms.
About this grant
This summary is based on the grant title only — the full abstract was not available.
Research project funded by Wellcome at University of Cambridge.
View the original record at the funder ↗
Researchers
Anthony Green (EPMC Awardee)
Related Research
Grants with similar aims, by meaning.
The molecular pathogenesis of atypical chronic myeloproliferative neoplasms and related diseases
Understanding the importance of MPL receptor density in the development of myeloproliferative neoplasms
The molecular pathogenesis of atypical chronic myeloproliferative neoplasms and related disorders
Developing Early Intervention Strategies for High-Risk Clonal Hematopoiesis
A First in Human Study of the Safety, Pharmacokinetics and Pharmacodynamics of JNJ-88549968, a T-cell redirecting Bi-specific Antibody Targeting Mutated CALR expression in Myeloproliferative Neoplasms
Original classification
Investigator Award in SciencePlain English summaries and category classifications on this site are generated by AI and may not perfectly reflect the original research. Is something wrong? Let us know